In part 6 of this Exclusive Interview, Dr. Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the ability to predict cardiovascular disease.

In this week's Homerun Slides, the technology currently and soon to be helping people to manage their diabetes.

Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver disease ranging from simple liver fat accumulation to severe hepatic necro-inflammation (nonalcoholic steatohepatitis or NASH), and eventually cirrhosis.

For many years cardiovascular disease has been the number one cause of death among diabetes patients. So getting a CV benefit from diabetes drugs is a definite plus. Over the past few weeks Dr. Aaron Vinik has been sharing his views on the values of Cycloset for both diabetes and …

Patients with type 2 diabetes usually do not die from diabetes, but from cardiovascular disease and strokes.

Benefits of exercise shown to depend on duration, not exercise type

Study finds linoleic acid has long-term benefits in diabetes prevention, arachidonic acid not harmful.

Statin therapy may be elevating risk of type 2 diabetes in high-risk adults.

SEARCH For Diabetes In Youth Study finds more at risk of developing diabetic peripheral neuropathy than previously thought.

By Guest Writer David Kliff, Publisher, Diabetic Investor: Although it has taken much longer than I anticipated, market dynamics are forcing companies to think differently and we are now on the verge of patients being prescribed diabetes management systems rather than individual pieces of the system.